|
STX3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
5.771400E-04 |
| Normal-vs-Stage3 |
3.5527136788005E-14 |
| Normal-vs-Stage4 |
1.6449952511266E-11 |
| Stage1-vs-Stage2 |
4.676100E-02 |
| Stage1-vs-Stage3 |
6.191000E-01 |
| Stage1-vs-Stage4 |
1.247400E-01 |
| Stage2-vs-Stage3 |
1.384780E-01 |
| Stage2-vs-Stage4 |
8.837700E-03 |
| Stage3-vs-Stage4 |
6.168400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
8.15270000000812E-05 |
| Normal-vs-Asian |
1.14050002775201E-09 |
| Caucasian-vs-AfricanAmerican |
8.402000E-01 |
| Caucasian-vs-Asian |
2.323000E-01 |
| AfricanAmerican-vs-Asian |
5.826600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.42561526420104E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
1.561370E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
3.73529995822963E-09 |
| Normal-vs-Age(81-100Yrs) |
2.496000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.231990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.588000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.343700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.470400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.392400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.184600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.768850E-01 |
| Classical-VS-Follicular |
1.81663999999637E-05 |
| Classical-VS-Other |
2.851000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
5.87839999999229E-05 |
| Tall-VS-Other |
5.726200E-02 |
| Tall-VS-Normal |
1.90270021960259E-11 |
| Follicular-VS-Other |
7.109400E-01 |
| Follicular-VS-Normal |
6.49849999999619E-05 |
| Other-VS-Normal |
5.230300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.08735284401973E-13 |
| Normal-vs-N1 |
1.08020037359324E-10 |
| N0-vs-N1 |
3.884400E-02 |
|
|
